Zhang Zhida, Ren Hui, Shen Gengyang, Qiu Ting, Liang De, Yang Zhidong, Yao Zhensong, Tang Jingjing, Jiang Xiaobing, Wei Qiushi
The First School of Clinic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
The First School of Clinic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Biomed Pharmacother. 2016 Dec;84:438-446. doi: 10.1016/j.biopha.2016.09.045. Epub 2016 Sep 28.
Glucocorticoid-induced postmenopausal osteoporosis is a severe osteoporosis, with high risk of major osteoporotic fractures. This severe osteoporosis urges more extensive and deeper basic study, in which suitable animal models are indispensable. However, no relevant review is available introducing this model systematically. Based on the recent studies on GI-PMOP, this brief review introduces the GI-PMOP animal model in terms of its establishment, evaluation of bone mass and discuss its molecular mechanism. Rat, rabbit and sheep with their respective merits were chosen. Both direct and indirect evaluation of bone mass help to understand the bone metabolism under different intervention. The crucial signaling pathways, miRNAs, osteogenic- or adipogenic- related factors and estrogen level may be the predominant contributors to the development of glucocorticoid-induced postmenopausal osteoporosis.
糖皮质激素诱导的绝经后骨质疏松症是一种严重的骨质疏松症,发生主要骨质疏松性骨折的风险很高。这种严重的骨质疏松症促使人们进行更广泛、更深入的基础研究,而合适的动物模型是必不可少的。然而,目前尚无系统介绍该模型的相关综述。基于最近对糖皮质激素诱导的绝经后骨质疏松症的研究,本简要综述从其建立、骨量评估方面介绍了糖皮质激素诱导的绝经后骨质疏松症动物模型,并探讨了其分子机制。选择了具有各自优点的大鼠、兔子和绵羊。对骨量的直接和间接评估有助于了解不同干预下的骨代谢。关键信号通路、微小RNA、成骨或成脂相关因子以及雌激素水平可能是糖皮质激素诱导的绝经后骨质疏松症发生的主要因素。